Regulating effects of transforming growth factor-β1 on gene expressions of MMP-1 and TIMP-1 mRNA in human hyaline chondrocytes
Qiyong Guo
Abstract
Qiyong Guo
Abstract
Objective To investigate the role of transforming growth factor -β1(TGF-β1) in regulating gene expression of the matrix metalloproteinase-1 (MMP-1) and its inhibitor, the tissue inhibitor of metalloproteinase -1(TIMP-1) in human hyaline chondrocytes so as to have a better understanding of the mechanism of cartilage injury in osteoarthritis. Methods In the experiment, human hyaline chondrocytes were harvested enzymatically and cultured in DMEM and given respectively TGF-β1 of 1 ng/mL, 10 ng/mL and 100 ng/mL, 1 ng/mL TGF-β1+10 ng/mL IL-1β, 10 ng/mL TGF-β1+10 ng/mL IL-1β, 100 ng/mL TGF-β1+10 ng/mL IL-1βbefore they were cultured for another 12 hours. The MMP-1 and TIMP-1 mRNA levels of passaged monolayer cell cultures of human hyaline chondrocyte were assessed by reverse transcriptase polymerase chain reaction (RT-PCR) and fluorescent quantitative PCR (FQ-PCR). Results Normal human chondrocytes expressed MMP-1 and TIMP-1 mRNA. In the groups treated with TGF-β1 and IL-1β, TGF-β1 could decrease the MMP-1 mRNA level, but increase TIMP-1 mRNA expression level. The difference was significant (P 0.05) and the levels of MMP-1 and TIMP-1 mRNA expression had significant association with the dosages of TGF-β1. Conclusion Our results show that TGF-β1 may have a crucial effect on chondrocytes by regulating the balance between the expressions of MMP-1 mRNA and TIMP-1 mRNA, which are known to be important in osteoarthritis development, and have an antagonistic effect on IL-1βin osteoarthritis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the role of transforming growth factor -β1(TGF-β1) in regulating gene expression of the matrix metalloproteinase-1 (MMP-1) and its inhibitor, the tissue inhibitor of metalloproteinase -1(TIMP-1) in human hyaline chondrocytes so as to have a better understanding of the mechanism of cartilage injury in osteoarthritis. Methods In the experiment, human hyaline chondrocytes were harvested enzymatically and cultured in DMEM and given respectively TGF-β1 of 1 ng/mL, 10 ng/mL and 100 ng/mL, 1 ng/mL TGF-β1+10 ng/mL IL-1β, 10 ng/mL TGF-β1+10 ng/mL IL-1β, 100 ng/mL TGF-β1+10 ng/mL IL-1βbefore they were cultured for another 12 hours. The MMP-1 and TIMP-1 mRNA levels of passaged monolayer cell cultures of human hyaline chondrocyte were assessed by reverse transcriptase polymerase chain reaction (RT-PCR) and fluorescent quantitative PCR (FQ-PCR). Results Normal human chondrocytes expressed MMP-1 and TIMP-1 mRNA. In the groups treated with TGF-β1 and IL-1β, TGF-β1 could decrease the MMP-1 mRNA level, but increase TIMP-1 mRNA expression level. The difference was significant (P 0.05) and the levels of MMP-1 and TIMP-1 mRNA expression had significant association with the dosages of TGF-β1. Conclusion Our results show that TGF-β1 may have a crucial effect on chondrocytes by regulating the balance between the expressions of MMP-1 mRNA and TIMP-1 mRNA, which are known to be important in osteoarthritis development, and have an antagonistic effect on IL-1βin osteoarthritis.
Key concepts: Chondrocyte, Matrix metalloproteinase, Messenger RNA, Transforming growth factor, Hyaline cartilage, Hyaline, Tissue inhibitor of metalloproteinase, Molecular biology